CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE: CRL · Wilmington, MA · Healthcare
$345.37+5.71 (+1.68%)Closed
Market Cap$16.48B
Cash$203.9Mmost recent
Runwayprofitable
P/E (TTM)—EPS $-2.91
52-Wk Range$149.93 – $345.37
Avg Volume942.8K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$345.37+89.0%
Pipeline
Drug candidates sponsored by CHARLES RIVER LABORATORIES INTERNATIONAL · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for CRL. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.